The relationship between serum ferritin levels and disease activity in systemic lupus erythematosus

Scandinavian Journal of Rheumatology

Volumn 32, Issue 4, 2003, Pages 225-228

  Beyan, E ^a   Beyan, Cengiz ^b   Demirezer, A ^a   Ertugrul E ^a   Uzuner, A ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Acute phase response; Serum ferritin; SLEDAI; Systemic lupus erythematosus

Indexed keywords

FERRITIN;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE MARKER; EVALUATION; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RATING SCALE; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ACUTE-PHASE REACTION; ADOLESCENT; ADULT; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; FEMALE; FERRITINS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 0142025364     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/03009740310003712     Document Type: Article

References (20)

1. Danieli MG, Paoletti P, Recchioni A, Gabrielli A, Danieli G. Serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and systemic idiopathic vasculitis. Scand J Rheumatol 1993;22:215-9.
2. Font J, Coca A, Molina R, Ballesta A, Cardellach F, Ingelmo M, et al. Serum beta 2-microglobulin as a marker of activity in systemic lupus erythematosus. Scand J Rheumatol 1986;15:201-5.
3. Dixon JS, Bird HA, Sitton NG, Pickup ME, Wright V. C-reactive protein in the serial assessment of disease activity in rheumatoid arthritis. Scand J Rheumatol 1984;13:39-44.
4. Borg EJ, Horst G, Limburg PC, Rijswijk MH, Kallenberg CGM. C-reactive protein levels during disease exacerbations and infections in Systemic Lupus Erythematosus: A prospective longitudinal study. J Rheumatol 1990;17:1642-8.
5. Ohta A, Yamaguchi M, Tsunematsu T, Kasukawa R, Mizushima H, Kashiwagi H, et al. Adult Still's disase: A multicenter survey of Japanese patients. J Rheumatol 1990;17:1058-63.
6. Ota T, Higashi S, Suzuki H, Eto S. Increased serum ferritin levels in adult Still's disease. Lancet 1987;1:562-3.
7. Nishiya K, Hashimoto K. Elevation of serum ferritin levels as a marker for active systemic lupus erythematosus. Clin Exp Rheumatol 1997;15:39-44.
8. Lim MK, Lee CK, Ju YS, Cho YS, Lee MS, Yoo B, et al. Serum ferritin as a serologic marker of activity in systemic lupus erythematosus. Rheumatol Int 2001;20:89-93.
9. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. The Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
10. Nossent JC. Course and prognostic value of Systemic Lupus Erythematosus Disease Activity Index in Black Caribbean patients. Semin Arthritis Rheum 1993;23:16-21.
11. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of SLE. Arthritis Rheum 1982;25:1271-7.
12. Arnett FC, Edworthy SM, Bloch DA. The American Rheumatism Association 1987 revised criteria for the classification of RA. Arthritis Rheum 1987;31:315-24.
13. Davis MJ, Dawes PT, Fowler PD, Sheeran TP, Shadforth MF, Ziade F, et al. Comparison and evaluation of a disease activity index for use in patients with rheumatoid arthritis. Br J Rheumatol 1990;29:111-5.
14. Klockars M, Weber T, Tanner P, Hellstrom PE, Pettersson T. Pleural fluid ferritin concentrations in human disease. J Clin Pathol 1985;38:818-24.
15. Nishiya K, Kawabata F, Ota Z. Elevated urinary ferritin in lupus nephritis. J Rheumatol 1989;16:1513-4.
16. Hesselink DA, Aarden LA, Swaak AJG. Profiles of the acute-phase reactants C-reactive protein and ferritin related to the disease course of patients with systemic lupus erythematosus. Scand J Rheumatol 2003;32:151-5.
17. Linker-Israeli M, Bakke AC, Kitridou RC, Gendler S, Gillis S, Horwitz DA. Defective production of interleukin-1 and interleukin-2 in patients with systemic lupus erythematosus (SLE). J Immunol 1983;130:2651-5.
18. Maury CPJ, Teppo AM. Tumor necrosis factor in the serum of patients with systemic lupus erythematosus. Arthritis Rheum 1989;32:146-50.
19. Spronk PE, Terborg EJ, Limburg PC, Kallenberg CGM. Plasma concentration of IL-6 in systemic lupus erythematosus; an indicator of disease activity? Clin Exp Immunol 1992;90:106-10.
20. Swaak AJ, van den Brink HG, Aarden LA. Cytokine production (IL-6 and TNF alpha) in whole blood cell cultures of patients with systemic lupus erythematosus. Scand J Rheumatol 1996;25:233-8.